These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34784875)

  • 21. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome.
    Liu M; Li G; Song X; Fan Y; Li C
    Sci Rep; 2023 Jun; 13(1):8915. PubMed ID: 37264095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
    Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: seronegative antiphospholipid-like syndrome.
    Duval A; Darnige L; Glowacki F; Copin MC; Martin De Lassalle E; Delaporte E; Auxenfants E
    J Am Acad Dermatol; 2009 Dec; 61(6):1076-8. PubMed ID: 19646781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
    Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
    Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.
    Stojanovich L; Djokovic A; Stanisavljevic N; Zdravkovic M
    Lupus; 2018 Apr; 27(5):858-863. PubMed ID: 29301476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary antiphospholipid syndrome with and without limb ischemia: A retrospective observational study.
    de Carvalho JF; Brandão Neto RA; Skare TL; Shoenfeld Y
    Lupus; 2023 Nov; 32(13):1486-1492. PubMed ID: 37852301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers.
    Pettee AD; Wasserman BA; Adams NL; McMullen W; Smith HR; Woods SL; Ratnoff OD
    Neurology; 1994 Mar; 44(3 Pt 1):399-405. PubMed ID: 8145905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
    Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
    Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sneddon syndrome: diagnostic value of antiphospholipid antibodies].
    Martínez Hernández PL; López Guzmán A; Espinosa Arranz E; Monereo Alonso A; Arnalich Fernández F
    Rev Clin Esp; 1991 Oct; 189(6):272-4. PubMed ID: 1763211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?
    Kontic M; Stojanovich L; Mijailović-Ivković M; Velinović M; Srnka J; Zdravkovic M
    Clin Exp Rheumatol; 2018; 36(1):56-61. PubMed ID: 28770705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome.
    da Silva Saraiva S; de Moraes Mazetto B; Quinteiro Tobaldine L; Pereira Colella M; Vinícius De Paula E; Annichinno-Bizzachi J; Andrade Orsi F
    Am J Hematol; 2017 Nov; 92(11):1163-1169. PubMed ID: 28762539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
    Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sneddon's syndrome (livedo reticularis and cerebrovascular lesions) with antiphospholipid antibodies and severe dementia in young man: a case report.
    Jura E; Palasik W; Meurer M; Palester-Chlebowczyk M; Czlonkowska A
    Acta Neurol Scand; 1994 Feb; 89(2):143-6. PubMed ID: 8191878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological manifestations of antiphospholipid syndrome.
    Rodrigues CE; Carvalho JF; Shoenfeld Y
    Eur J Clin Invest; 2010 Apr; 40(4):350-9. PubMed ID: 20192975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sneddon's syndrome: clinical and laboratory analysis of 10 cases.
    Bolayir E; Yilmaz A; Kugu N; Erdogan H; Akyol M; Akyuz A
    Acta Med Okayama; 2004 Apr; 58(2):59-65. PubMed ID: 15255506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid syndrome and cutaneous vasoocclusive disorders.
    Grattan CE; Burton JL
    Semin Dermatol; 1991 Sep; 10(3):152-9. PubMed ID: 1931563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Height associated with different clinical expressions in primary antiphospholipid syndrome female patients.
    Freire Carvalho J; Pereira Torales MB; Figueiredo Sousa MI; Larocca Skare T
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):585-590. PubMed ID: 35113434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.